Category:
Prophylactic Biological Products
CAS NO:
179324-69-7
Standard:
USP,
Bortezomib is a proteasome inhibitor used in oncology. Synthesized via complex peptide coupling, its molecular formula is C18H25B N4O6 (CAS: 179324-69-7).
Requires strict cold chain storage at -20°C. Clinical use mandates monitoring for peripheral neuropathy and thrombocytopenia. Handling must follow cytotoxic drug safety protocols to prevent occupational exposure.